|Department||Department of Clinical Pharmacology|
Professor Len Seymour is a co-founder of Hybrid Systems Ltd and a leading UK authority on genetic medicine. Len holds the Chair of Genetic Therapies at the University of Oxford and is also the President of the British Society for Gene Therapy. He has authored over 100 primary scientific publications and holds several patents in the field of molecular and macromolecular therapeutics.
His research group is particularly interest in the interface of stem cells and genetic technology, focussing on strategies for improving motility and engraftment of therapeutic cells within sites of tissue damage including
delivery of therapeutic viruses and gene constructs.